EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

Treatment of rheumatoid arthritis (RA) may differ among rheumatologists and currently, clear and consensual international recommendations on RA treatment are not available. In this paper recommendations for the treatment of RA with synthetic and biological disease-modifying antirheumatic drugs (DMAR...

Descripció completa

Dades bibliogràfiques
Autors principals: Smolen, Josef S, Landewé, Robert, Breedveld, Ferdinand C, Dougados, Maxime, Emery, Paul, Gaujoux-Viala, Cecile, Gorter, Simone, Knevel, Rachel, Nam, Jackie, Schoels, Monika, Aletaha, Daniel, Buch, Maya, Gossec, Laure, Huizinga, Tom, Bijlsma, Johannes W J W, Burmester, Gerd, Combe, Bernard, Cutolo, Maurizio, Gabay, Cem, Gomez-Reino, Juan, Kouloumas, Marios, Kvien, Tore K, Martin-Mola, Emilio, McInnes, Iain, Pavelka, Karel, van Riel, Piet, Scholte, Marieke, Scott, David L, Sokka, Tuulikki, Valesini, Guido, van Vollenhoven, Ronald, Winthrop, Kevin L, Wong, John, Zink, Angela, van der Heijde, Désirée
Format: Text
Idioma:English
Publicat: BMJ Group 2010
Matèries:
Recommendations
Accés en línia:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2935329/
https://www.ncbi.nlm.nih.gov/pubmed/20444750
http://dx.doi.org/10.1136/ard.2009.126532

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2935329/
https://www.ncbi.nlm.nih.gov/pubmed/20444750
http://dx.doi.org/10.1136/ard.2009.126532

Ítems similars